971 related articles for article (PubMed ID: 28682563)
1. [Non vitamin-K dependent oral anticoagulants (NOACs) in chronic kidney disease patients with non-valvular atrial fibrillation].
Di Lullo L; Barbera V; Bellasi A; Cozzolino M; Russo D; Otranto G; Santoboni F; Ronco C
G Ital Nefrol; 2017 Apr; 34(2):58-73. PubMed ID: 28682563
[TBL] [Abstract][Full Text] [Related]
2. Nonvitamin K-dependent oral anticoagulants (NOACs) in chronic kidney disease patients with atrial fibrillation.
Di Lullo L; Ronco C; Cozzolino M; Russo D; Russo L; Di Iorio B; De Pascalis A; Barbera V; Galliani M; Vitaliano E; Campana C; Santoboni F; Bellasi A
Thromb Res; 2017 Jul; 155():38-47. PubMed ID: 28482261
[TBL] [Abstract][Full Text] [Related]
3. [NOACs and Chronic kidney disease].
Di Lullo L; Barbera V; Bellasi A; Cozzolino M; Russo D; Otranto G; Santoboni F; Ronco C
G Ital Nefrol; 2017 Mar; 34(Suppl 69):188-204. PubMed ID: 28682039
[TBL] [Abstract][Full Text] [Related]
4. Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF II]).
Steinberg BA; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Kowey PR; Mahaffey KW; Peterson ED; Piccini JP;
Am J Cardiol; 2017 May; 119(10):1590-1595. PubMed ID: 28363354
[TBL] [Abstract][Full Text] [Related]
5. Nonvitamin K Anticoagulant Agents in Patients With Advanced Chronic Kidney Disease or on Dialysis With AF.
Chan KE; Giugliano RP; Patel MR; Abramson S; Jardine M; Zhao S; Perkovic V; Maddux FW; Piccini JP
J Am Coll Cardiol; 2016 Jun; 67(24):2888-99. PubMed ID: 27311528
[TBL] [Abstract][Full Text] [Related]
6. The use of anticoagulants in chronic kidney disease: Common point of view of cardiologists and nephrologists.
Domienik-Karłowicz J; Tronina O; Lisik W; Durlik M; Pruszczyk P
Cardiol J; 2020; 27(6):868-874. PubMed ID: 30912573
[TBL] [Abstract][Full Text] [Related]
7. Atrial fibrillation in dialysis patients: is there a place for non-vitamin K antagonist oral anticoagulants?
Mlodawska E; Lopatowska P; Malyszko J; Banach M; Sobkowicz B; Covic A; Tomaszuk-Kazberuk A
Int Urol Nephrol; 2018 Sep; 50(9):1633-1642. PubMed ID: 29785661
[TBL] [Abstract][Full Text] [Related]
8. Nonvitamin K Oral Anticoagulants in Patients With Atrial Fibrillation and Severe Renal Dysfunction.
Mahmood M; Lip GYH
Rev Esp Cardiol (Engl Ed); 2018 Oct; 71(10):847-855. PubMed ID: 29958809
[TBL] [Abstract][Full Text] [Related]
9. Atrial Fibrillation and Thromboembolism in Patients With Chronic Kidney Disease.
Lau YC; Proietti M; Guiducci E; Blann AD; Lip GYH
J Am Coll Cardiol; 2016 Sep; 68(13):1452-1464. PubMed ID: 27659468
[TBL] [Abstract][Full Text] [Related]
10. Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation.
Heidbuchel H; Verhamme P; Alings M; Antz M; Diener HC; Hacke W; Oldgren J; Sinnaeve P; Camm AJ; Kirchhof P
Europace; 2015 Oct; 17(10):1467-507. PubMed ID: 26324838
[TBL] [Abstract][Full Text] [Related]
11. Non-vitamin K antagonist oral anticoagulants in atrial fibrillation accompanying mitral stenosis: the concept for a trial.
De Caterina R; John Camm A
Europace; 2016 Jan; 18(1):6-11. PubMed ID: 26450845
[TBL] [Abstract][Full Text] [Related]
12. Fitting the right non-vitamin K antagonist oral anticoagulant to the right patient with non-valvular atrial fibrillation: an evidence-based choice.
Li YG; Pastori D; Lip GYH
Ann Med; 2018 Jun; 50(4):288-302. PubMed ID: 29608110
[TBL] [Abstract][Full Text] [Related]
13. Novel oral anticoagulants in patients with chronic kidney disease and atrial fibrillation.
Stamellou E; Floege J
Nephrol Dial Transplant; 2018 Oct; 33(10):1683-1689. PubMed ID: 29206932
[TBL] [Abstract][Full Text] [Related]
14. Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction.
Potpara TS; Ferro CJ; Lip GYH
Nat Rev Nephrol; 2018 May; 14(5):337-351. PubMed ID: 29578207
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulation in atrial fibrillation and co-existent chronic kidney disease: efficacy versus safety.
Salim I; Al Suwaidi J; Ghadban W; Salam AM
Expert Opin Drug Saf; 2013 Jan; 12(1):53-63. PubMed ID: 23095103
[TBL] [Abstract][Full Text] [Related]
16. Comparative effectiveness of novel oral anticoagulants in UK patients with non-valvular atrial fibrillation and chronic kidney disease: a matched cohort study.
Loo SY; Coulombe J; Dell'Aniello S; Brophy JM; Suissa S; Renoux C
BMJ Open; 2018 Jan; 8(1):e019638. PubMed ID: 29371284
[TBL] [Abstract][Full Text] [Related]
17. Novel oral anticoagulants in non-valvular atrial fibrillation.
Potpara TS; Lip GY
Best Pract Res Clin Haematol; 2013 Jun; 26(2):115-29. PubMed ID: 23953900
[TBL] [Abstract][Full Text] [Related]
18. New oral anticoagulants in patients with chronic kidney disease.
Belmar Vega L; de Francisco ALM; Bada da Silva J; Galván Espinoza L; Fernández Fresnedo G
Nefrologia; 2017; 37(3):244-252. PubMed ID: 27939514
[TBL] [Abstract][Full Text] [Related]
19. Non-Vitamin K-Dependent Oral Anticoagulants for Nonvalvular Atrial Fibrillation in Patients With CKD: Pragmatic Considerations for the Clinician.
Shroff GR; Stoecker R; Hart A
Am J Kidney Dis; 2018 Nov; 72(5):717-727. PubMed ID: 29728318
[TBL] [Abstract][Full Text] [Related]
20. Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with chronic kidney disease: A systematic review and network meta-analysis.
Andò G; Capranzano P
Int J Cardiol; 2017 Mar; 231():162-169. PubMed ID: 28007305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]